Cite
HARVARD Citation
Shi, L. et al. (2022). An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety. Nanoscale advances. 4 (3), pp. 952-966. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Shi, L. et al. (2022). An esterase-activatable prodrug formulated liposome strategy: potentiating the anticancer therapeutic efficacy and drug safety. Nanoscale advances. 4 (3), pp. 952-966. [Online].